Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

DAMMANN

Showing results (361-370 of 1,352) with videos related to

Pageof 136
Sort By:
Regulatory Toxicology and Pharmacology : RTP|November 18, 2004
The stability of historical control data for common neoplasms in laboratory rats and the implications for carcinogenic risk assessmentHenk Tennekes, Wolfgang Kaufmann, Martina Dammann, et al.
Nucleic Acids Research|May 25, 1993
Chromatin structures and transcription of rDNA in yeast Saccharomyces cerevisiaeR Dammann, R Lucchini, T Koller, et al.
British Journal of Clinical Pharmacology|October 1, 1983
Effect of ranitidine and cimetidine twice daily on the 24 h intragastric acidity in manH G Dammann, W Friedl, P Müller, et al.
Research in Experimental Medicine. Zeitschrift Fur Die Gesamte Experimentelle Medizin Einschliesslich Experimenteller Chirurgie|January 1, 1981
The new histamine H2-receptor antagonist ranitidine. Duration of actionH G Dammann, P Müller, H Kather, et al.
Arzneimittel-Forschung|January 1, 1982
[SKF 93479, a newly developed histamine H2-receptor antagonist. / Effect on gastric potential difference in the presence and absence of acetylsalicylic acid]P Müller, H G Dammann, R Kessler, et al.
Digestive Diseases and Sciences|August 1, 1982
Prevention of taurocholate-induced drop in gastric potential difference with ranitidine in manP Müller, H Kather, B Simon, et al.
Deutsche Medizinische Wochenschrift (1946)|December 12, 1980
[Ranitidine, a newly developed histamine H2-receptor antagonist. First experimental and clinical results]B Simon, H G Dammann, P Müller, et al.
MMW, Munchener Medizinische Wochenschrift|May 27, 1983
[Inhibition of the proton pump with omeprazole. A new principle of ulcer therapy?]P Müller, H G Dammann, H Seitz, et al.
Oncology Reports|November 4, 2009
Frequent promoter hypermethylation of tumor-related genes in head and neck squamous cell carcinomaKatrin Steinmann, Annett Sandner, Undraga Schagdarsurengin, et al.
European Journal of Clinical Pharmacology|January 1, 1989
Comparison of the gastroduodenal tolerance of tenoxicam and diclofenac Na. A double-blind, endoscopically controlled study in healthy volunteersP Müller, H G Dammann, U Leucht, et al.
Pageof 136

Showing results (361-370 of 1,352) with videos related to

Sort By:
Pageof 136
Regulatory Toxicology and Pharmacology : RTP|November 18, 2004
The stability of historical control data for common neoplasms in laboratory rats and the implications for carcinogenic risk assessmentHenk Tennekes, Wolfgang Kaufmann, Martina Dammann, et al.
Nucleic Acids Research|May 25, 1993
Chromatin structures and transcription of rDNA in yeast Saccharomyces cerevisiaeR Dammann, R Lucchini, T Koller, et al.
British Journal of Clinical Pharmacology|October 1, 1983
Effect of ranitidine and cimetidine twice daily on the 24 h intragastric acidity in manH G Dammann, W Friedl, P Müller, et al.
Research in Experimental Medicine. Zeitschrift Fur Die Gesamte Experimentelle Medizin Einschliesslich Experimenteller Chirurgie|January 1, 1981
The new histamine H2-receptor antagonist ranitidine. Duration of actionH G Dammann, P Müller, H Kather, et al.
Arzneimittel-Forschung|January 1, 1982
[SKF 93479, a newly developed histamine H2-receptor antagonist. / Effect on gastric potential difference in the presence and absence of acetylsalicylic acid]P Müller, H G Dammann, R Kessler, et al.
Digestive Diseases and Sciences|August 1, 1982
Prevention of taurocholate-induced drop in gastric potential difference with ranitidine in manP Müller, H Kather, B Simon, et al.
Deutsche Medizinische Wochenschrift (1946)|December 12, 1980
[Ranitidine, a newly developed histamine H2-receptor antagonist. First experimental and clinical results]B Simon, H G Dammann, P Müller, et al.
MMW, Munchener Medizinische Wochenschrift|May 27, 1983
[Inhibition of the proton pump with omeprazole. A new principle of ulcer therapy?]P Müller, H G Dammann, H Seitz, et al.
Oncology Reports|November 4, 2009
Frequent promoter hypermethylation of tumor-related genes in head and neck squamous cell carcinomaKatrin Steinmann, Annett Sandner, Undraga Schagdarsurengin, et al.
European Journal of Clinical Pharmacology|January 1, 1989
Comparison of the gastroduodenal tolerance of tenoxicam and diclofenac Na. A double-blind, endoscopically controlled study in healthy volunteersP Müller, H G Dammann, U Leucht, et al.
Pageof 136